Flex Pharma to Present at the BIO CEO & Investor Conference
Click to Tweet
Flex Pharma, Inc. (NASDAQ: FLKS) today announced that Company management will present a corporate overview at the 2017 BIO CEO
& Investor Conference on Tuesday, February 14, 2017 at 10:00 a.m.
A live webcast of Flex Pharma’s presentations at these conferences may be accessed in the Investor section of the Company’s
website at www.flex-pharma.com. Please log on to the Flex Pharma website approximately 15 minutes prior to the scheduled
webcast to ensure adequate time for any software downloads that may be required. A replay of the webcast will be available on Flex
Pharma’s website for 2 weeks following each presentation.
About Flex Pharma
Flex Pharma, Inc. is a biotechnology company that is developing innovative and proprietary treatments for cramps and spasms
associated with the severe neurological diseases of ALS, MS and peripheral neuropathies such as Charcot-Marie-Tooth (CMT). Flex
Pharma was founded by National Academy of Science members Rod MacKinnon, M.D. (2003 Nobel Laureate), and Bruce Bean, Ph.D.,
recognized leaders in the fields of ion channels and neurobiology, along with Chair and CEO Christoph Westphal, M.D., Ph.D.
Flex Pharma, Inc.
Elizabeth Woo, 617-874-1829
SVP, Investor Relations & Corporate Communications
irdept@flex-pharma.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170207006296/en/